Target intelligence / Profile preview

Programmed cell death protein 1 receptor (PD-1)

Target
PD-1
Molecular classification
Receptor, Immune checkpoint, Immunoglobulin superfamily
01

Overview

Programmed cell death protein 1 receptor (PD‑1) is a transmembrane protein expressed primarily on the surface of activated T cells and B cells. It functions as an immune checkpoint that downregulates immune responses by binding its ligands PD-L1 or PD-L2. This interaction suppresses T-cell inflammatory activity and promotes self-tolerance by inhibiting T-cell proliferation and cytokine production. While this mechanism prevents autoimmunity under normal conditions, it can also allow cancer cells to evade immune surveillance. Therapeutic antibodies targeting the PD‑1 pathway block this inhibitory signal to reactivate antitumor immunity in various cancers[1][2][4][6].

Other names
CD279PDCD1Programmed death-1 receptorProgrammed cell death 1 receptor
02

Mechanism of action

Immune checkpoint inhibition (blockade of PD‑1/PD‑L1 interaction to enhance T-cell activation and antitumor immunity)[1][4]

03

Biological functions

Immune response regulationSignal transductionApoptosis (programmed cell death)
04

Disease associations

CancerAutoimmune disease
05

Safety considerations

Risk of immune-related adverse events (e.g., colitis, pneumonitis, hepatitis)
06

Interacting drugs

2 more in the full profile.

07

Biomarkers

Tumor PD-L1 expression[1]Tumor mutational burden[1]

Beyond the preview

Go deeper on Programmed cell death protein 1 receptor (PD-1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Programmed cell death protein 1 receptor (PD-1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call